In conclusion, the development of ALK-TKI resistance is associated with increased PD-L1 expression in both tumor and stromal compartments, a functional deficit in CD8+ T cell cytolytic activity despite their presence, and a significant increase in Treg cells. The gene discussed is CD8A; the disease is neoplasm.